Stay updated on SAR442720 Combo Study in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.

Latest updates to the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page
- Check6 days agoChange DetectedThe study record for the terminated vociprotafib combination trial is displayed, including its design, eligibility criteria, locations, outcome measures, and posted results. It also provides study documents and information about requesting participant-level data.SummaryDifference83%

- Check13 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedAn NIH-wide notice was added, linking to transition updates and FAQs and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. The site revision identifier advances from v3.7.0 to v3.7.1.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page remains on a 403 Forbidden error screen, with no visible content or layout changes.SummaryDifference0.2%

Stay in the know with updates to SAR442720 Combo Study in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.